Natriuretic Peptides as Diagnostic Test: Lessons From the First 5 Years of Clinical Application

Heart Failure Clinics

Volumn 2, Issue 3, 2006, Pages 299-309

  Daniels, Lori B ^a   Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; N TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ALGORITHM; BLOOD ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DYSPNEA; ECHOCARDIOGRAPHY; HEART MUSCLE; HEART RIGHT VENTRICLE FAILURE; HUMAN; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LUNG DISEASE; LUNG EDEMA; LUNG EMBOLISM; MEDICAL DECISION MAKING; OBESITY; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ALGORITHMS; COMORBIDITY; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY DISEASES; LUNG DISEASES; NATRIURETIC PEPTIDES; OBESITY;

EID: 33750798021     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.08.008     Document Type: Review

References (47)

1. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 6 (1989) 884-888
2. Davidson N.C., and Struthers A.D. Brain natriuretic peptide. J Hypertens 12 4 (1994) 329-336
3. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24 3 (2003) 341-356
4. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19
5. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343 8895 (1994) 440-444
6. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 2 (2001) 379-385
7. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
8. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 7 (2004) 647-654
9. Maisel A., Hollander J.E., Guss D., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 6 (2004) 1328-1333
10. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 8 (2005) 948-954
11. Wang T.J., Larson M.G., Levy D., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90 3 (2002) 254-258
12. Maisel A.S., Clopton P., Krishnaswamy P., et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147 6 (2004) 1078-1084
13. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 2 (2006) 345-353
14. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 5 (2002) 976-982
15. Morrison L.K., Harrison A., Krishnaswamy P., et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 2 (2002) 202-209
16. McCullough P.A., Hollander J.E., Nowak R.M., et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10 3 (2003) 198-204
17. Berman B., Spragg R., and Maisel A. B-type natriuretic peptide (BNP) levels in differentiating congestive heart failure from acute respiratory distress syndrome (ARDS). Abstracts from the 75th Annual Scientific Meeting of the American Heart Association. Circulation 106 19 (2002) SII-647
18. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 20 (2003) 2545-2547
19. Bando M., Ishii Y., Sugiyama Y., et al. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93 7 (1999) 507-514
20. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 8 (2000) 865-870
21. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 1 (1998) 202-208
22. McCullough P.A., and Sandberg K.R. B-type natriuretic peptide and renal disease. Heart Fail Rev 8 4 (2003) 355-358
23. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 1 (2006) 91-97
24. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 3 (2003) 571-579
25. Vickery S., Price C.P., John R.I., et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 46 4 (2005) 610-620
26. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 1 (1993) 82-91
27. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction: correlation with left ventricular systolic dysfunction. Eur Heart J 21 18 (2000) 1514-1521
28. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 14 (2001) 1014-1021
29. Rudiger A., Gasser S., Fischler M., et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34 8 (2006) 2140-2144
30. Jones A.E., and Kline J.A. Elevated brain natriuretic peptide in septic patients without heart failure. Ann Emerg Med 42 5 (2003) 714-715
31. Tomaru Ki K., Arai M., Yokoyama T., et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 34 6 (2002) 649-659
32. Tanaka T., Kanda T., Takahashi T., et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res 32 1 (2004) 57-61
33. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 4 (2004) 505-513
34. Charpentier J., Luyt C.E., Fulla Y., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 3 (2004) 660-665
35. Yildiz R., Yildirim B., Karincaoglu M., et al. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 20 7 (2005) 1115-1120
36. Wong F., Siu S., Liu P., et al. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?. Clin Sci (Lond) 101 6 (2001) 621-628
37. Henriksen J.H., Gotze J.P., Fuglsang S., et al. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52 10 (2003) 1511-1517
38. Kohno M., Horio T., Yasunari K., et al. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 42 8 (1993) 1059-1064
39. Schultz M., Faber J., Kistorp C., et al. N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol (Oxf) 60 1 (2004) 54-59
40. Jin H., Afonso L., Singh A., et al. Case report: recurrent heart failure with preserved ejection fraction but markedly elevated BNP in a 51-year-old female on hemodialysis with oversized AV fistula. Int J Cardiol 110 3 (2006) 429-430
41. Wang T.J., Larson M.G., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 5 (2004) 594-600
42. Mehra M.R., Uber P.A., Park M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 9 (2004) 1590-1595
43. Krauser D.G., Lloyd-Jones D.M., Chae C.U., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149 4 (2005) 744-750
44. Daniels L.B., Clopton P., Bhalla V., et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151 5 (2006) 1006-1012
45. Horwich T.B., Hamilton M.A., and Fonarow G.C. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47 1 (2006) 85-90
46. Yoshimura M., Yasue H., Okumura K., et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87 2 (1993) 464-469
47. Leya F.S., Arab D., Joyal D., et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 45 11 (2005) 1900-1902